Replimune Group, Inc. — Director's Dealing 2023

Jun 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2023-06-01

Reporting Person: Peeples-Dyer Veleka (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-01	Employee Stock Option (right to buy)	$18.48	A	50400	Acquired	2033-06-01	Common Stock (50400)	Direct

Footnotes

F1: 25% of the shares underlying this stock option vest on June 1, 2024, and the remainder of the shares underlying this stock option vest in 24 approximately equal monthly installments thereafter.